𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Infliximab reduces resource use and costs in Crohn's disease


Book ID
121633267
Publisher
Adis International Limited (now part of Wolters Kluwer Health)
Year
2013
Weight
111 KB
Volume
681
Category
Article
ISSN
1173-5503

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Resource use and societal costs for Croh
✍ Johan Mesterton; Linus JΓΆnsson; Sven H.C. Almer; Ragnar Befrits; Ingalill Friis- πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 150 KB

## Background: The usual onset of Crohn's disease (CD) is between 15 and 30 years of age, thus affecting people during their most economically productive period in life. Methods: This study intended to estimate societal costs and health-related quality of life (HRQoL) in Swedish patients in diffe

Infliximab Use in Luminal Crohn's Diseas
✍ Richter, James A.; Bickston, Stephen J. πŸ“‚ Article πŸ“… 2006 πŸ› Elsevier Science 🌐 English βš– 176 KB